drugset
drugset / Trial / NCT01121666

Multi-centre Study to Compare Efficacy and Safety of AFOLIA and Gonal-f in Women for Assisted Reproductive Treatment

NCT01121666 ↗

Phase 3 Completed 460 enrolled Finox AG
RandomizedParallel-groupSingle-blindTreatment

Summary

Ther purpose of this study is to show equivalence between AFOLIA and Gonal-f® with regard to the number of oocytes retrieved in women for assisted reproductive treatment.

Timeline

Start
2010-06
Primary completion
2011-12
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Gonal-f Protein / enzyme biologic 150 iu Subcutaneous

Indications

infertility disorder